SEEING WHAT MATTERS
We support radiologists with our AI-based tools during MRI reportings. This enables them to perform more precise and objective assessments even more quickly.
— Product Innovation: AI for Prostate Diagnosis
YOUR SOLUTION FOR AUTOMATED PROSTATE DIAGNOSIS
Our latest CE-certified product enables AI-based evaluations of prostate MRIs. Lesions are automatically detected and classified according to PI-RADS 2.1.
— Our AI-based solutions
YOUR SOFTWARE FOR MRI ASSESSMENTS FROM HEAD TO KNEE.
Sharpen your focus and save time in your daily routine, seamlessly integrated into your workflow.
Everything at a glance in your PACS
Fast analysis of MRI images integrated in your workflow
Automatically generated reports incl. norm value comparison
Highest security for your data through local hosting
Customers who trust in us.
YOUR SOLUTION FOR QUANTITATIVE NEURO-IMAGING.
Our advanced tool for the AI-based evaluation of your brain MRIs. Provides security and saves valuable time - certified and tested hundreds of thousands of times in the daily radiological routine.
Saves time on tedious tasks
through automatic segmentation of physiological structures
More safety in case of critical findings
through automatic detection of pathological structures
Saves time on tedious tasks
through automatic segmentation of physiological structures
More safety in case of critical findings
through automatic detection of pathological structures
Spedali Civili Brescia University of Brescia Italy
Ihre Radiologie, Berlin - Germany
Radiologie am Rhein - Germany
evidia GmbH
DIE RADIOLOGIE Munich
Spedali Civili Brescia University of Brescia Italy
Ihre Radiologie, Berlin - Germany
Radiologie am Rhein - Germany
Radiologist-in-Chief
evidia GmbH
DIE RADIOLOGIE Munich
Our md-suite is compatible with all common PACS providers. In addition, we are working on deeper integrations with numerous other partners.
— About mediaire
WHAT SETS
US APART.
From radiologists
for radiologists
Our products are all developed in close cooperation with radiologists. This is how we ensure that your requirements are met.
Optimized for the daily routine in radiology
Our products are proven in daily routine of hospitals and medical practices. There, high precision and fair pricing allow for large scale applications.
Highest spectrum of MRI applications on the market
Our md-suite already offers a wide range of applications. However we constantly develop new products to make your daily life even easier.
— Scientific evidence
AI in facts and figures
We offer a transparent and flexible pricing model. You pay according to volume. Without risk. No hidden costs.
Test our software free of charge and without obligation!
We offer a transparent and flexible pricing model. You pay according to volume. Without risk. No hidden costs.
Test our software
free of charge and
without obligation!
— News & Press
Dienstag, 27.07.2022
Crazy days in Rome at #AINR – our suite #mdbrain has attracted huge interest and our booth was always crowded. Moreover first local experience showing gains in diagnostic precision and efficiency was presented!
Mittwoch, 01.07.2022
Crazy days in Rome at #AINR – our suite #mdbrain has attracted huge interest and our booth was always crowded. Moreover first local experience showing gains in diagnostic precision and efficiency was presented!
Freitag, 03.05.2022
mediaire and SECTRA work together to make AI-based solutions like mdbrain available to customers globally. The full growth potential and better address the needs of large internationally operating clients.
Second external validation of the mdbrain module 'Aneurysm Detection' published
The study by the University Hospital Bonn examines the impact of AI tools on the quality of findings in aneurysm detection using MRI images. For the study, the mdbrain Aneurysm Module was used for automatic detection of intracranial aneurysms in TOF sequences.
Active Surveillance Made Easy - The Future of Prostate Examination
Active Surveillance is increasingly establishing itself as a pioneering treatment for prostate cancer. We met with Prof. Dr. Michaely from the MVZ Karlsruhe for a discussion on this topic. In this brief interview, he answers questions regarding the significance of AI for further establishment, as well as the potential influence of contrast agents on the implementation of Active Surveillance.
World's first AI tool for prostate cancer monitoring available
With the update of mdprostate 1.3, the first fully automatic tool for identification and classification of lesions according to PI-RADS 2.1 with longitudinal evaluation is now available. Additionally, the performance of the tool has been significantly improved.